Name: etomidate: an intravenous hypnotic agent. first report on clinical and experimental experience (en Inglés)
Price: 73020.00 CLP
Availability: InStock
Author: Doenicke, Alfred
ISBN: 9783540084853

portada etomidate: an intravenous hypnotic agent. first report on clinical and experimental experience (en Inglés)

Formato

Libro Físico

Ilustrado por

Alfred Doenicke

Editorial

Springer

Autor

Doenicke, Alfred

Año

1977

Idioma

Inglés

N° páginas

158

Encuadernación

Tapa Blanda

Dimensiones

24.4 x 17.0 x 0.9 cm

Peso

0.29 kg.

ISBN

3540084851

ISBN13

9783540084853

Categorías

Dolor y tratamiento del dolor
Farmacología

etomidate: an intravenous hypnotic agent. first report on clinical and experimental experience (en Inglés)

Alfred Doenicke (Ilustrado por) · Springer · Tapa Blanda

Libro Nuevo

$ 73.020

$ 132.760

Ahorras: $ 59.740

45% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Jueves 27 de Junio y el Martes 09 de Julio.

Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.

Reseña del libro "etomidate: an intravenous hypnotic agent. first report on clinical and experimental experience (en Inglés)"

The question how to induce general anaesthesia without problems has been asked repeatedly by anaesthetists and pharmacologists. P. A. JANSSEN developed etomidate and published this substance in 1971 as "a potent short-acting and relatively atoxic intravenous hypnotic agent in rats". In 1974 after several years of experimental and clinical trial the barbiturate-free hypnotic etomidate (soon marketed as Hypnomidate) was introduced to numerous auditors at the occasion of the IV. European Congress of Anaesthesiologists in Madrid. As the authors extended their essays, the actuality of the present book is given. The conclusion mentions the new solution of etomidate base in 35 % propylene glycol. It is expected that the disadvantageous effects - venous pain during injection and associated involuntary muscle movement- will largely be eliminated by using the new formula of etomidate after premedication of fentanyl. Mlinchen, August 1977 Alfred DOENICKE TABLE OF CONTENTS The Experimental Pharmacology of Etomidate, a New Potent, Short-Acting Intravenous Hypnotic (R. S. RENEMAN and P. A. JANSSEN) -. . . . -- 1 Protein Binding of Etomidate (G. A. MANNES and A. DOENICKE) ----. . . 6 The Effect of Intra-Arterial Injection of Etomidate and Thiopental on the Skeletal Muscle- and Arterial Wall-Structures (R. S. RENEMAN, F. VERHEYEN, R. KRUGER, W. VAN GERVEN and M. BORGES) . . -. . -- 9 Interaction between Etomidate and the Antihypertensive Agents Propanolol andoC-Methyl-Dopa (R. S. RENEMAN, W. VAN GERVEN and R. KRUGER) --. -. . . 15 Teratogenicity of Etomidate (A. DOENICKE and M. HAEHL) -. --. -.